Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis

INTRODUCTION: Global rating scale measures are useful for assessing the clinical relevance of patient change. Cariprazine, a dopamine D(3) and D(2) receptor partial agonist, is FDA‐approved for the adult treatment of acute manic/mixed episodes of bipolar I disorder and schizophrenia. Post hoc evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Durgam, Suresh, Earley, Willie, Lu, Kaifeng, Németh, György, Laszlovszky, István, Volk, Stephen, Litman, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765496/
https://www.ncbi.nlm.nih.gov/pubmed/29119668
http://dx.doi.org/10.1111/ijcp.13037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765496/
https://www.ncbi.nlm.nih.gov/pubmed/29119668
http://dx.doi.org/10.1111/ijcp.13037

Ejemplares similares